Half-year report · HY
3001.TEDINET S100YVW3
Period2026-01-01 → 2026-06-30
Filed2026-08-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥20.8bn | 2026-01-01 → 2026-06-30 | Cons. | Net sales |
| Revenue | ¥40.7bn | 2025-01-01 → 2025-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥20.8bn | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Operating income | ¥3.7bn | 2026-01-01 → 2026-06-30 | Cons. | Operating income |
| Operating income | ¥3.2bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Ordinary income | ¥4.5bn | 2026-01-01 → 2026-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥7.2bn | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.9bn | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥7.5bn | 2026-01-01 → 2026-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥5.1bn | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥5.4bn | 2026-01-01 → 2026-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥5.8bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.5bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥5.4bn | 2026-01-01 → 2026-06-30 | Cons. | Profit loss |
| Net income | ¥3.6bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Total assets | ¥152.4bn | at 2026-06-30 | Cons. | Assets |
| Total assets | ¥153.0bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥137.1bn | at 2025-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥50.3bn | at 2026-06-30 | Cons. | Liabilities |
| Total liabilities | ¥53.3bn | at 2025-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥102.0bn | at 2026-06-30 | Cons. | Net assets |
| Net assets / equity | ¥99.8bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥89.1bn | at 2025-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥33.8bn | at 2026-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥31.5bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥13.1bn | at 2026-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.4bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.8bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.2bn | at 2024-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥5.0bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥8.2bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥5.1bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.1bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥609m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥802m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥3.1bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥5.7bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥4.3bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥169.68 | 2026-01-01 → 2026-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥180.73 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥110.26 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 65.6% | at 2026-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.8% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.8% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 50
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2026-01-01 → 2026-06-30 | ¥1.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2026-01-01 → 2026-06-30 | ¥1.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥218m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2026-01-01 → 2026-06-30 | ¥73m |
| Reconciling Itemsreconciling | revenue | 2026-01-01 → 2026-06-30 | −¥238m |
| Reconciling Itemsreconciling | revenue intersegment | 2026-01-01 → 2026-06-30 | −¥238m |
| Reconciling Itemsreconciling | segment profit | 2026-01-01 → 2026-06-30 | −¥463m |
| Machinery Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥4.2bn |
| Machinery Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥4.2bn |
| Machinery Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥557m |
| Pharmaceuticals Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥5.8bn |
| Pharmaceuticals Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥5.8bn |
| Pharmaceuticals Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥454m |
| Real Estate Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥6.0bn |
| Real Estate Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥6.0bn |
| Real Estate Businessreportable segment | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥19m |
| Real Estate Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥2.5bn |
| Textiles Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥3.5bn |
| Textiles Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥3.5bn |
| Textiles Businessreportable segment | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥1m |
| Textiles Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥580m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2026-01-01 → 2026-06-30 | ¥21.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2026-01-01 → 2026-06-30 | ¥20.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥238m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2026-01-01 → 2026-06-30 | ¥4.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-01-01 → 2025-06-30 | ¥1.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-01-01 → 2025-06-30 | ¥1.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥214m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-01-01 → 2025-06-30 | ¥82m |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥235m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥235m |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥499m |
| Machinery Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥4.8bn |
| Machinery Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥4.8bn |
| Machinery Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥641m |
| Pharmaceuticals Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥5.6bn |
| Pharmaceuticals Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥5.6bn |
| Pharmaceuticals Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥447m |
| Real Estate Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥5.7bn |
| Real Estate Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥5.7bn |
| Real Estate Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥19m |
| Real Estate Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥2.2bn |
| Textiles Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥3.3bn |
| Textiles Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥3.3bn |
| Textiles Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥1m |
| Textiles Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥332m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-01-01 → 2025-06-30 | ¥21.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-01-01 → 2025-06-30 | ¥20.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥235m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-01-01 → 2025-06-30 | ¥3.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 542
| Item | Context | Value | Unit |
|---|---|---|---|
| Cash and cash equivalents | Prior1InterimInstant | 10786000000 | JPY |
| Cash and cash equivalents | InterimInstant | 13118000000 | JPY |
| Sales related expenses sga | Prior1InterimDuration | 309000000 | JPY |
| Sales related expenses sga | InterimDuration | 285000000 | JPY |
| Advertising expenses sga | Prior1InterimDuration | 313000000 | JPY |
| Advertising expenses sga | InterimDuration | 301000000 | JPY |
| Salaries and allowances oecna | Prior1InterimDuration | 1252000000 | JPY |
| Salaries and allowances oecna | InterimDuration | 1262000000 | JPY |
| Provision for bonuses sga | Prior1InterimDuration | 134000000 | JPY |
| Provision for bonuses sga | InterimDuration | 142000000 | JPY |
| Retirement benefit expenses sga | Prior1InterimDuration | -171000000 | JPY |
| Retirement benefit expenses sga | InterimDuration | -209000000 | JPY |
| Welfare expenses sga | Prior1InterimDuration | 271000000 | JPY |
| Welfare expenses sga | InterimDuration | 270000000 | JPY |
| Depreciation sga | Prior1InterimDuration | 101000000 | JPY |
| Depreciation sga | InterimDuration | 102000000 | JPY |
| Research and development expenses sga | Prior1InterimDuration | 863000000 | JPY |
| Research and development expenses sga | InterimDuration | 854000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E00524-000RealEstateBusinessReportableSegmentsMember | 5678000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E00524-000PharmaceuticalsBusinessReportableSegmentsMember | 5587000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E00524-000MachineryBusinessReportableSegmentsMember | 4774000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E00524-000TextilesBusinessReportableSegmentsMember | 3334000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 1380000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 20755000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReconcilingItemsMember | - | JPY |
| Revenues from external customers | Prior1InterimDuration | 20755000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E00524-000RealEstateBusinessReportableSegmentsMember | 19000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E00524-000PharmaceuticalsBusinessReportableSegmentsMember | - | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E00524-000MachineryBusinessReportableSegmentsMember | - | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E00524-000TextilesBusinessReportableSegmentsMember | 1000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 214000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 235000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_ReconcilingItemsMember | -235000000 | JPY |
| Transactions with other segments | Prior1InterimDuration | - | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E00524-000RealEstateBusinessReportableSegmentsMember | 5698000000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E00524-000PharmaceuticalsBusinessReportableSegmentsMember | 5587000000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E00524-000MachineryBusinessReportableSegmentsMember | 4774000000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E00524-000TextilesBusinessReportableSegmentsMember | 3335000000 | JPY |
| Net sales | Prior1InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 1595000000 | JPY |
| Net sales | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 20990000000 | JPY |
| Net sales | Prior1InterimDuration_ReconcilingItemsMember | -235000000 | JPY |
| Net sales | Prior1InterimDuration | 20755000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E00524-000RealEstateBusinessReportableSegmentsMember | 2152000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E00524-000PharmaceuticalsBusinessReportableSegmentsMember | 447000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E00524-000MachineryBusinessReportableSegmentsMember | 641000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E00524-000TextilesBusinessReportableSegmentsMember | 332000000 | JPY |
| Operating income | Prior1InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 82000000 | JPY |
| Operating income | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 3655000000 | JPY |
| Operating income | Prior1InterimDuration_ReconcilingItemsMember | -499000000 | JPY |
| Operating income | Prior1InterimDuration | 3156000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |